Close

Form 8-K Proto Labs Inc For: Mar 15

March 16, 2022 4:16 PM EDT

News and research before you hear about it on CNBC and others. Claim your 1-week free trial to StreetInsider Premium here.
prlb20220315_8k.htm
false 0001443669 0001443669 2022-03-15 2022-03-15
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
 
Washington, D.C. 20549
 
FORM 8-K
 
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
 
March 15, 2022
Date of report (Date of earliest event reported)
 
 
PROTO LABS, INC.
(Exact Name of Registrant as Specified in its Charter)
 
 
Minnesota
 
001-35435
 
41-1939628
(State of Incorporation)
 
(Commission File Number)
 
(I.R.S. Employer Identification No.)
 
 
5540 Pioneer Creek Drive
Maple Plain, Minnesota
 
55359
(Address of Principal Executive Offices)
 
(Zip Code)
 
     
 
(763) 479-3680
 
 
(Registrant’s Telephone Number, Including Area Code)
 
 
 
Not Applicable
 
 
(Former Name or Former Address, if Changed Since Last Report)
 
 
 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
 
       Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
 
       Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
 
       Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
 
       Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 
 
Securities registered pursuant to Section 12(b) of the Act:
 
Title of each class
Trading Symbol(s)
Name of each exchange on which registered
Common Stock, Par Value $0.001 Per Share
PRLB
New York Stock Exchange
 
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 or Rule 12b-2 of the Securities Exchange Act of 1934.
 
Emerging growth company
 
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
 
 

 
 
Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
 
On March 16, 2022, Proto Labs, Inc. (the “Company”) announced that Arthur R. Baker III, Chief Technology Officer, is stepping down from his role with the Company, effective April 15, 2022 (the “Effective Date”). Upon the Effective Date, Dr. Robert Bodor, Chief Executive Officer of the Company, will serve as the interim Chief Technology Officer while the Company conducts a search for a new leader. Upon his departure, Mr. Baker will be entitled to receive the severance benefits described in Section 5(A) of the Company's Form of Executive Severance Agreement filed as Exhibit 99.2 to the Company's Current Report on Form 8-K filed with the Commission on August 2, 2019.
 
Item 9.01.     Financial Statements and Exhibits.
 
(d) Exhibits
 
104     Cover Page Interactive Data File (formatted as Inline XBRL)
 
2

 
SIGNATURES
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
PROTO LABS, INC.
Date: March 16, 2022
/s/ Robert Bodor
Robert Bodor
President and Chief Executive Officer
 
3


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

SEC Filings